Literature DB >> 25002528

Insulin receptor substrates are essential for the bioenergetic and hypertrophic response of the heart to exercise training.

Christian Riehle1, Adam R Wende2, Yi Zhu3, Karen J Oliveira3, Renata O Pereira1, Bharat P Jaishy1, Jack Bevins3, Steven Valdez3, Junghyun Noh3, Bum Jun Kim3, Annie Bello Moreira3, Eric T Weatherford4, Rajkumar Manivel4, Tenley A Rawlings3, Monika Rech3, Morris F White5, E Dale Abel6.   

Abstract

Insulin and insulin-like growth factor 1 (IGF-1) receptor signaling pathways differentially modulate cardiac growth under resting conditions and following exercise training. These effects are mediated by insulin receptor substrate 1 (IRS1) and IRS2, which also differentially regulate resting cardiac mass. To determine the role of IRS isoforms in mediating the hypertrophic and metabolic adaptations of the heart to exercise training, we subjected mice with cardiomyocyte-specific deletion of either IRS1 (CIRS1 knockout [CIRS1KO] mice) or IRS2 (CIRS2KO mice) to swim training. CIRS1KO hearts were reduced in size under basal conditions, whereas CIRS2KO hearts exhibited hypertrophy. Following exercise swim training in CIRS1KO and CIRS2KO hearts, the hypertrophic response was equivalently attenuated, phosphoinositol 3-kinase (PI3K) activation was blunted, and prohypertrophic signaling intermediates, such as Akt and glycogen synthase kinase 3β (GSK3β), were dephosphorylated potentially on the basis of reduced Janus kinase-mediated inhibition of protein phosphatase 2a (PP2A). Exercise training increased peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) protein content, mitochondrial capacity, fatty acid oxidation, and glycogen synthesis in wild-type (WT) controls but not in IRS1- and IRS2-deficient hearts. PGC-1α protein content remained unchanged in CIRS1KO but decreased in CIRS2KO hearts. These results indicate that although IRS isoforms play divergent roles in the developmental regulation of cardiac size, these isoforms exhibit nonredundant roles in mediating the hypertrophic and metabolic response of the heart to exercise.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25002528      PMCID: PMC4135616          DOI: 10.1128/MCB.00426-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  The conserved phosphoinositide 3-kinase pathway determines heart size in mice.

Authors:  T Shioi; P M Kang; P S Douglas; J Hampe; C M Yballe; J Lawitts; L C Cantley; S Izumo
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Akt1 is required for physiological cardiac growth.

Authors:  Brian DeBosch; Iya Treskov; Traian S Lupu; Carla Weinheimer; Attila Kovacs; Michael Courtois; Anthony J Muslin
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

Review 3.  The fuzzy logic of physiological cardiac hypertrophy.

Authors:  Gerald W Dorn
Journal:  Hypertension       Date:  2007-03-26       Impact factor: 10.190

4.  Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes.

Authors:  G G Neri Serneri; M Boddi; P A Modesti; I Cecioni; M Coppo; L Padeletti; A Michelucci; A Colella; G Galanti
Journal:  Circ Res       Date:  2001-11-23       Impact factor: 17.367

Review 5.  Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway.

Authors:  Ichiro Shiojima; Kenneth Walsh
Journal:  Genes Dev       Date:  2006-12-15       Impact factor: 11.361

6.  Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart.

Authors:  E D Abel; H C Kaulbach; R Tian; J C Hopkins; J Duffy; T Doetschman; T Minnemann; M E Boers; E Hadro; C Oberste-Berghaus; W Quist; B B Lowell; J S Ingwall; B B Kahn
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

7.  Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy.

Authors:  Ji Luo; Julie R McMullen; Cassandra L Sobkiw; Li Zhang; Adam L Dorfman; Megan C Sherwood; M Nicole Logsdon; James W Horner; Ronald A DePinho; Seigo Izumo; Lewis C Cantley
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

8.  Cardiac hypertrophy caused by peroxisome proliferator- activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signaling.

Authors:  Sandra Sena; Isaac R Rasmussen; Adam R Wende; Alfred P McQueen; Heather A Theobald; Nicole Wilde; Renata Oliveira Pereira; Sheldon E Litwin; Joel P Berger; E Dale Abel
Journal:  Endocrinology       Date:  2007-09-06       Impact factor: 4.736

9.  A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy.

Authors:  Brian T O'Neill; Jaetaek Kim; Adam R Wende; Heather A Theobald; Joseph Tuinei; Jonathan Buchanan; Aili Guo; Vlad G Zaha; Don K Davis; John C Schell; Sihem Boudina; Benjamin Wayment; Sheldon E Litwin; Tetsuo Shioi; Seigo Izumo; Morris J Birnbaum; E Dale Abel
Journal:  Cell Metab       Date:  2007-10       Impact factor: 27.287

10.  PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis.

Authors:  Teresa C Leone; John J Lehman; Brian N Finck; Paul J Schaeffer; Adam R Wende; Sihem Boudina; Michael Courtois; David F Wozniak; Nandakumar Sambandam; Carlos Bernal-Mizrachi; Zhouji Chen; John O Holloszy; Denis M Medeiros; Robert E Schmidt; Jeffrey E Saffitz; E Dale Abel; Clay F Semenkovich; Daniel P Kelly
Journal:  PLoS Biol       Date:  2005-03-15       Impact factor: 8.029

View more
  44 in total

Review 1.  Advances in understanding mechanisms and therapeutic targets to treat comorbid depression and cardiovascular disease.

Authors:  Brittany S Pope; Susan K Wood
Journal:  Neurosci Biobehav Rev       Date:  2020-06-26       Impact factor: 8.989

2.  Exercise training improves vascular mitochondrial function.

Authors:  Song-Young Park; Matthew J Rossman; Jayson R Gifford; Leena P Bharath; Johann Bauersachs; Russell S Richardson; E Dale Abel; J David Symons; Christian Riehle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-29       Impact factor: 4.733

Review 3.  Cardiac adaptation to exercise training in health and disease.

Authors:  Dae Yun Seo; Hyo-Bum Kwak; Amy Hyein Kim; Se Hwan Park; Jun Won Heo; Hyoung Kyu Kim; Jeong Rim Ko; Sam Jun Lee; Hyun Seok Bang; Jun Woo Sim; Min Kim; Jin Han
Journal:  Pflugers Arch       Date:  2019-04-23       Impact factor: 3.657

4.  Peroxisome proliferator-activated receptor-γ coactivator 1 α1 induces a cardiac excitation-contraction coupling phenotype without metabolic remodelling.

Authors:  Maija Mutikainen; Tomi Tuomainen; Nikolay Naumenko; Jenni Huusko; Boris Smirin; Svetlana Laidinen; Krista Kokki; Heidi Hynynen; Seppo Ylä-Herttuala; Merja Heinäniemi; Jorge L Ruas; Pasi Tavi
Journal:  J Physiol       Date:  2016-12-01       Impact factor: 5.182

Review 5.  Skeletal muscle mitochondrial remodeling in exercise and diseases.

Authors:  Zhenji Gan; Tingting Fu; Daniel P Kelly; Rick B Vega
Journal:  Cell Res       Date:  2018-08-14       Impact factor: 25.617

Review 6.  Evidence for distinct effects of exercise in different cardiac hypertrophic disorders.

Authors:  Emily J Johnson; Brad P Dieter; Susan A Marsh
Journal:  Life Sci       Date:  2015-01-26       Impact factor: 5.037

7.  Phosphoinositide dependent protein kinase 1 is required for exercise-induced cardiac hypertrophy but not the associated mitochondrial adaptations.

Authors:  Junghyun Noh; Adam R Wende; Curtis D Olsen; Bumjun Kim; Jack Bevins; Yi Zhu; Quan-Jiang Zhang; Christian Riehle; E Dale Abel
Journal:  J Mol Cell Cardiol       Date:  2015-10-22       Impact factor: 5.000

8.  Exercise and metformin counteract altered mitochondrial function in the insulin-resistant brain.

Authors:  Gregory N Ruegsegger; Patrick M Vanderboom; Surendra Dasari; Katherine A Klaus; Parijat Kabiraj; Christina B McCarthy; Claudia F Lucchinetti; K Sreekumaran Nair
Journal:  JCI Insight       Date:  2019-09-19

Review 9.  Molecular Mechanisms Underlying Cardiac Adaptation to Exercise.

Authors:  Rick B Vega; John P Konhilas; Daniel P Kelly; Leslie A Leinwand
Journal:  Cell Metab       Date:  2017-05-02       Impact factor: 27.287

Review 10.  Recent advances of adapter proteins in the regulation of heart diseases.

Authors:  Li Tao; Linna Jia; Yuntian Li; Chengyun Song; Zheng Chen
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.